|
市場調査レポート
商品コード
1463835
にきび治療薬市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：治療クラス別、剤形別、タイプ別、にきびタイプ別、流通チャネル別、地域別Acne Medication Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, and Geography |
||||||
|
|
|||||||
| にきび治療薬市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：治療クラス別、剤形別、タイプ別、にきびタイプ別、流通チャネル別、地域別 |
|
出版日: 2024年03月04日
発行: The Insight Partners
ページ情報: 英文 229 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
世界のにきび治療薬市場は、2022年の77億7,400万米ドルから2030年には118億米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR 5.40％で成長すると推定されます。
本レポートで紹介するにきび治療薬市場予測は、このマーケットプレースの利害関係者が成長戦略を計画するのに役立ちます。市場成長を促進する主な要因は、深刻なにきび問題の有病率の増加と新薬の発売です。しかし、にきび薬に伴う副作用がにきび薬市場の成長を制限しています。さらに、にきび治療薬市場の動向には、オーガニックで自然な治療に対するニーズの高まりが含まれます。
にきび治療薬市場の市場機会
にきび治療薬市場に先端技術とデータ主導型アプローチを採用することで、研究開発の新たな道が開かれます。患者データを収集・分析することで、研究者はにきびの根本的原因に関する貴重な洞察を得ることができ、治療反応のパターンと動向を特定し、治療介入のための新たな潜在的標的を発見することができます。これにより、新規薬剤、革新的な治療戦略、にきび患者の多様なニーズに合わせたよりパーソナライズされたスキンケア製品の開発を推進することができます。人工知能（AI）、機械学習アルゴリズム、遺伝子検査、その他の最先端ツールを活用することで、ヘルスケアプロバイダーは膨大なデータを分析し、患者固有の皮膚状態、遺伝的素因、ライフスタイル要因、治療反応をより深く理解できるようになった。このパーソナライズド・アプローチにより、患者一人ひとりのニーズに対応するために特別に設計されたオーダーメイドの治療計画を策定することが可能になります。
2021年3月、Thorne HealthTechの子会社でヘルスインテリジェンス企業であるOnegevity社は、美容・パーソナルケア製品の世界的トップメーカーの1つであるユニリーバと提携し、にきびの介入と治療に対するより個別化されたアプローチを可能にしました。この科学的共同研究は、マルチオミクス（異なる生物学的分野の統合）の可能性を調査し、にきび治療への個別化アプローチを可能にすることを目的としています。この共同研究は、人の健康に影響を与える何十億もの生物学的特性の評価を可能にするOnegevityのAIと機械学習機能を活用することで、カスタマイズされたにきび治療計画を可能にする新しい診断モデルを作成することを目的としています。パーソナライズされた治療計画は、にきび治療薬への反応に影響を及ぼす可能性のある患者固有の特性や要因を考慮することで、治療効果を最適化するのに役立ちます。このような患者固有のデータに基づいて、ヘルスケアプロバイダーは、その特定の個人にとってより効果的である可能性の高い治療法を処方することができます。これにより、にきびの治療が成功する可能性が向上し、副作用や有害反応の可能性が減少するため、患者の転帰が改善し、満足度が向上します。このように、パーソナライズされた治療計画を設計するための先進技術とデータ主導型アプローチの統合は、にきび治療薬市場における技術革新、成長、患者の転帰改善のための大きな機会を生み出しています。
にきび治療薬市場を阻害する要因
経口抗生物質、レチノイド、ホルモン療法を含む多くの従来の全身性にきび治療薬には、皮膚の乾燥、刺激感、光線過敏症、胃腸不快感、まれに重篤な全身性副作用など、さまざまな潜在的副作用が伴う。このような潜在的な副作用は、患者やヘルスケア提供者の間に懸念を引き起こし、特定のにきび治療薬の採用、特に長期使用に対するためらいにつながっています。副作用はまた、治療アドヒアランスの欠如にもつながり、耐えがたい、あるいは望ましくない副作用のために特定の薬剤を中止したり、避けたりすることもあります。その結果、消費者は、副作用を最小限に抑えながら有効性を優先する高度な製剤や治療法への傾倒を示し、新規の、より忍容性の高い、より優れたにきび治療薬への絶え間ないニーズがもたらされます。そのため、にきび治療薬に伴う副作用がにきび治療薬市場の成長を制限しています。
にきび治療薬市場セグメント別概要
2022年のにきび治療薬市場は、治療クラス別ではレチノイドセグメントが最大のシェアを占めており、同セグメントは2022年～2030年の間に大きなCAGRを記録すると予測されています。医師の処方箋がなければ購入できないレチノイドは、ビタミンAを主成分としており、レチノールと同様の働きをするが、にきび治療においてはるかに強力であり、より成功しています。レチノイドは経口カプセルと外用療法があります。トレチノイン、アダパレン、イソトレチノインはよく知られたレチノイドであり、イソトレチノインの経口製剤はロアキュタンと呼ばれることもあります。レチノイドは、患者の体重1kgあたり、外用薬では0.1～1％、内服薬では0.5～1mgの用量で処方されることが多いです。
剤形によって、にきび治療薬市場は外用薬と内服薬に分類されます。2022年のにきび治療薬市場では、外用薬セグメントが最大のシェアを占めています。同分野はさらに、2022年から2030年にかけて市場で大きなCAGRを記録すると予測されています。外用製剤は、にきびの管理と治療において重要な役割を果たし、患部の皮膚に直接有効成分を送達します。様々なタイプのにきび外用薬には、ジェル、クリーム、ローション、フォーム、溶液などがあり、それぞれが特定のにきび懸念や肌タイプに対応するように調整されています。これらの製剤には一般的に、レチノイド、過酸化ベンゾイル、サリチル酸、抗生物質などの成分が含まれており、それぞれがにきび吹き出物との闘いにおいて明確な役割を果たしています。
タイプ別に見ると、世界のにきび治療薬市場は処方薬と市販薬に分類されます。処方薬セグメントは2022年に最大の市場シェアを占めました。皮膚科医またはヘルスケアプロバイダーは通常、個人のにきびのタイプ、重症度、以前の治療に対する反応性を徹底的に評価した後に薬を処方します。処方されるにきび治療薬には、局所治療薬、内服薬、併用療法、特定のにきび懸念に対処するために調整された特殊製剤など、さまざまな選択肢があります。処方薬は、中等度から重度のにきび患者を対象に、的を絞った強力な解決策を提供するものです。
にきび治療薬市場は、形態によって小売店、薬局・薬店、その他に区分されます。2022年には、薬局・薬店セグメントがより大きな市場シェアを占めていました。薬局・薬店は、そのアクセスのしやすさ、プライバシーの保護、（個人医と比較して）手頃な価格により、医療サービス、消耗品、知識の重要な供給源となっています。近年、薬局・薬店は、さまざまな病気や病状の管理を支援することによって健康を増進させる能力で、多くの国々で認知されています。薬局やドラッグストアには、多くの場合、知識豊富なスタッフがおり、個々の肌タイプや悩みに応じて適切なにきび治療薬を選択できるよう顧客を指導しています。
にきび治療薬市場：地理的概要
にきび治療薬市場の調査範囲は、北米、欧州、アジア太平洋、中東・アフリカ、中南米です。2022年には、北米が世界のにきび治療薬市場で最大のシェアを占めました。
にきびは、ゴミ、油、皮脂、古い角質が毛根に詰まることによって引き起こされる皮膚疾患です。米国皮膚科学会によると、にきびは米国で最も蔓延している病気で、毎年5,000万人もの米国人がにきびに苦しんでいます。米国人のにきび発症率の増加と、それに伴う様々な革新的にきび治療薬の発売により、同国のにきび治療薬市場は拡大すると予測されています。さらに、身だしなみ、皮膚の健康、外見への注目が高まっていることも、にきび治療薬の需要を後押ししています。技術の進歩や研究により、効能が改善され副作用が最小限に抑えられた革新的なにきび治療製品が開発され、米国におけるにきび治療薬市場の成長にさらに貢献しています。
アジア太平洋地域は、2022年から2030年にかけて最も高いCAGRを記録すると推定されます。この地域は予測期間中に最も速いCAGRを記録すると予想されます。アジア太平洋地域では、中国がにきび治療薬の最大市場です。中国のにきび治療薬市場は様々な要因によって推進されています。特筆すべきは、AIを活用した遠隔医療の普及が皮膚科医療に革命をもたらし、治療へのアクセスを改善し、同じ治療においてより良い個別化を提供していることです。AIDERMAは、AIによる皮膚患者の診断と治療のための中国初の総合プラットフォームです。相談、継続的な教育、支援された診断と治療がAIDERMAの主要な提供物です。90種類以上の一般的な皮膚病が、診断と治療の補助のために提供されます。これは、診断と潜在的な治療方針を提供する簡単な手順であると主張しています。中国の医師が乾癬、湿疹、アトピー性皮膚炎を診断できるアプリケーションであるAIDDAには、7,000人以上の臨床医が登録しています。
にきび治療薬市場に関する報告書の作成にあたり参照した主な一次情報および二次情報には、世界銀行データ、国民保健サービス（NHS）、EMA（欧州医薬品庁）、WHO（世界保健機関）などがあります。
目次
第1章 イントロダクション
第2章 エグゼクティブサマリー
- 主要な洞察
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 にきび治療薬市場情勢
- PEST分析
- 外用薬と内服薬の価格分析
- にきび治療を受ける患者層
第5章 にきび治療薬市場- 主な市場力学
- にきび治療薬市場- 主な市場力学
- 主要市場促進要因
- 重症にきびの有病率の増加
- 新薬の発売
- 主な市場抑制要因
- にきび治療薬に伴う副作用
- 主な市場機会
- 最先端技術とデータ主導型戦略に基づく個別化治療プログラム
- 今後の動向
- オーガニック・ナチュラル治療へのニーズの高まり
- 促進要因と抑制要因の影響
第6章 にきび治療薬市場-世界市場分析
第7章 にきび治療薬市場分析-治療クラス別
- レチノイド
- 過酸化ベンゾイル
- 抗生物質
- サリチル酸
- その他
第8章 にきび治療薬市場分析-剤形別
- 外用薬
- 経口薬
第9章 にきび治療薬市場分析-タイプ別
- 処方薬
- 市販薬
第10章 にきび治療薬市場分析-にきびタイプ別
- 非炎症性にきび
- 炎症性にきび
第11章 にきび治療薬市場分析にきび治療薬市場分析-流通チャネル別
- 薬局・ドラッグストア
- 小売店
- eコマース
第12章 にきび治療薬市場- 地域別分析
- 北米
- 米国
- カナダ
- メキシコ
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他の欧州
- アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋
- 中東・アフリカ
- サウジアラビア
- 南アフリカ
- アラブ首長国連邦
- その他の中東・アフリカ
- 中南米
- ブラジル
- アルゼンチン
- その他の中南米
第13章 にきび治療薬市場：業界情勢
- にきび治療薬市場の成長戦略
- 有機的成長戦略
- 無機的成長戦略
- ファルマピエルと他社にきび治療薬の製品比較
第14章 企業プロファイル
- Teva Pharmaceutical Industries Ltd
- Mayne Pharma Group Ltd
- Almirall SA
- Johnson & Johnson
- Sun Pharmaceutical Industries Ltd
- Bausch Health Companies Inc
- Centro Internacional de Cosmiatria SA de CV
- Galderma SA
- Pfizer Inc
- GSK Plc
- Viatris Inc
- Somar Sapi De CV
- Pierre Fabre SA
- Carnot Technologies
- Italmex SA
第15章 付録
List Of Tables
- Table 1. Acne Medication Market Segmentation
- Table 2. Topical Medication
- Table 3. Oral Medication
- Table 4. Patient Population undergoing Acne Treatment from 2020-2023
- Table 5. Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
- Table 6. Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
- Table 7. Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
- Table 8. Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
- Table 9. Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
- Table 10. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 11. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 12. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 13. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 14. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 15. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
- Table 16. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 17. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 18. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 19. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 20. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 21. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 22. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 23. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 24. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 25. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 26. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 27. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 28. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 29. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 30. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 31. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 32. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 33. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 34. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 35. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 36. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
- Table 37. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 38. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 39. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 40. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 41. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 42. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 43. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 44. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 45. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 46. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 47. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 48. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 49. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 50. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 51. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 52. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 53. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 54. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 55. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 56. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 57. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 58. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 59. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 60. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 61. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 62. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 63. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 64. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 65. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 66. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 67. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 68. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 69. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 70. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 71. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 72. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
- Table 73. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 74. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 75. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 76. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 77. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 78. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 79. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 80. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 81. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 82. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 83. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 84. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 85. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 86. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 87. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 88. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 89. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 90. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 91. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 92. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 93. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 94. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 95. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 96. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 97. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 98. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 99. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 100. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 101. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 102. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 103. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 104. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 105. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 106. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 107. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 108. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
- Table 109. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 110. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 111. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 112. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 113. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 114. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 115. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 116. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 117. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 118. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 119. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 120. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 121. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 122. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 123. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 124. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 125. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 126. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 127. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 128. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 129. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 130. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 131. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 132. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 133. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 134. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
- Table 135. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 136. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 137. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 138. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 139. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 140. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 141. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 142. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 143. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 144. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 145. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
- Table 146. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
- Table 147. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
- Table 148. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
- Table 149. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
- Table 150. Recent Organic Growth Strategies in Acne Medication Market
- Table 151. Recent Inorganic Growth Strategies in the Acne Medication Market
- Table 152. Glossary of Terms, Acne Medication Market
List Of Figures
- Figure 1. Acne Medication Market Segmentation, by Geography
- Figure 2. PEST Analysis
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Acne Medication Market Revenue (US$ Million), 2022-2030
- Figure 5. Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
- Figure 6. Retinoids: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 7. Benzoyl Peroxide: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 8. Antibiotics: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 9. Salicylic Acid: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 10. Others: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 11. Acne Medication Market Share (%) - by Formulation (2022 and 2030)
- Figure 12. Topical Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Oral Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 14. Acne Medication Market Share (%) - by Type (2022 and 2030)
- Figure 15. Prescription Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 16. Over-the-Counter Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 17. Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
- Figure 18. Non-Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 20. Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
- Figure 21. Pharmacies and Drug Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 22. Retail Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 23. E-Commerce: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 24. Acne Medication Market Breakdown by Region, 2022 and 2030 (%)
- Figure 25. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 26. North America: Acne Medication Market- Revenue and Forecast to 2030(US$ Million)
- Figure 27. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
- Figure 28. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 29. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 30. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 31. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 32. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
- Figure 33. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
- Figure 34. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 35. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 36. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 37. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 38. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 39. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 40. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 41. Asia Pacific: Acne Medication Market- Revenue and Forecast to 2030(US$ Million)
- Figure 42. Asia Pacific: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
- Figure 43. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 44. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 45. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 46. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 47. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 48. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 49. Middle East & Africa: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 50. Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 51. Middle East and Africa: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
- Figure 52. Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 53. South Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 54. UAE: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 55. Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 56. South and Central America: Acne Medication Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 57. South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 58. Brazil: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 59. Argentina: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 60. Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
- Figure 61. Growth Strategies in Acne Medication Market
The global acne medication market is expected to reach US$ 11.80 billion in 2030 from US$ 7.774 billion in 2022. The market is estimated to grow with a CAGR of 5.40% from 2022 to 2030.
The acne medication market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. Key factors driving the market growth are the increasing prevalence of severe acne problems and the launch of novel drugs. However, side effects associated with acne medication limit the growth of the acne medication market. Moreover, acne medication market trends include the upsurge in need for organic and natural treatments.
Market Opportunities of Acne Medication Market
Adopting advanced technologies and data-driven approaches in the acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to better understand a patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.
In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the acne medication market.
Factor Hampering Acne Medication Market
Many traditional and systemic acne treatments, including oral antibiotics, retinoids, and hormonal therapies, are associated with a range of potential adverse effects, including skin dryness, irritation, photosensitivity, gastrointestinal discomfort, and, in rare cases, more severe systemic side effects. These potential adverse reactions have raised concerns among patients and healthcare providers, leading to hesitance in the adoption of certain acne medications, particularly for long-term use. Side effects also result in the lack of treatment adherence, as individuals may opt to discontinue or avoid specific medications due to intolerable or undesirable side effects. Consequently, consumers show an inclination toward advanced formulations and treatment modalities that prioritize efficacy while minimizing adverse reactions, introducing a constant need for novel, more tolerable, and better-tolerated acne medications. Thus, side effects associated with acne medication limit the growth of the acne medication market.
Acne Medication Market: Segmental Overview
The retinoid segment held the largest acne medication market share, based on therapeutic class, in 2022 and the same segment is anticipated to register a significant CAGR in the market during 2022-2030. Retinoids, which can be only bought with a doctor's prescription, contain vitamin A as a primary ingredient; they function similarly to retinol but they are far more potent and more successful in treating acne. Retinoids are available as oral capsules and topical therapies. Tretinoin, adapalene, and isotretinoin are well-known retinoids; the oral formulation of isotretinoin is sometimes referred to as Roaccutane. Retinoids are frequently prescribed in dosages of 0.1-1% for topical applications and 0.5-1 mg for oral applications per kilogram of patient weight.
Based on formulation, the acne medication market is classified into topical medication and oral medication. The topical medication segment held the largest share of the acne medication market in 2022. The same segment is further anticipated to record a significant CAGR in the market from 2022 to 2030. Topical formulations play a vital role in managing and treating acne, offering targeted delivery of active ingredients directly to the affected skin areas. Various types of topical acne medication include gel, cream, lotion, foam, and solution, each tailored to address specific acne concerns and skin types. These formulations commonly contain ingredients such as retinoids, benzoyl peroxide, salicylic acid, and antibiotics, each serving distinct roles in combating acne breakouts.
Based on type, the global acne medication market is classified into prescription medicines and over-the-counter medicines. The prescription medicines segment held a largest market share in 2022. Dermatologists or healthcare providers typically prescribe medications after a thorough assessment of the individual's acne type, severity, and responsiveness to previous treatments. Prescription acne medications encompass a range of options, including topical treatments, oral medications, combination therapies, and specialized formulations tailored to address specific acne concerns. Prescription medications are meant to offer targeted and potent solutions for individuals with moderate to severe forms of the condition.
The acne medication market is segmented into retail stores, pharmacies and drug stores, and others based on mode. In 2022, the pharmacies and drug stores segment held a larger market share. With their accessibility, privacy, and affordability (compared to private physicians), pharmacies and drug stores are vital sources of health services, supplies, and knowledge. Pharmacies and drug stores have gained recognition in numerous nations in recent years for their ability to enhance health by aiding in the management of a broad range of illnesses and medical conditions. Pharmacies and drug stores often have knowledgeable staff to guide customers on selecting the right acne medication based on individual skin types and concerns.
Acne Medication Market: Geographical Overview
In terms of geography, the scope of the acne medication market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2022, North America held the largest share of the global acne medication market.
Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications. Additionally, the growing focus on personal grooming, skin health, and external appearance fuels the demand for acne medications. Technological advancements and research have led to the development of innovative acne treatment products with improved efficacy and minimal side effects, contributing further to the acne medication market growth in the US, as people in this country are more willing to invest in high-quality products that deliver desired results.
Asia Pacific is estimated to register the highest CAGR during 2022-2030. This region is expected to record the fastest CAGR during the forecast period. In Asia Pacific, China is the largest market for acne medication. The acne medication market in China is propelled by various factors. Notably, the widespread adoption of AI-enabled telemedicine has revolutionized dermatological care, improving access to treatments and providing better personalization in the same. AIDERMA is China's first all-inclusive platform for AI-assisted skin patient diagnosis and therapy. Consultation, ongoing education, and supported diagnosis and therapy are the prime offerings of AIDERMA. More than 90 types of common skin illnesses are provided for assisted diagnosis and treatment. This claims to be a straightforward procedure that offers a diagnostic and potential course of action. More than 7,000 clinicians have registered for AIDDA, an application that allows doctors in China to diagnose psoriasis, eczema, and atopic dermatitis.
A few of the major primary and secondary sources referred to while preparing the report on the acne medication market are the World Bank Data, National Health Service (NHS), EMA (European Medicines Agency), and WHO (World Health Organization).
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Acne Medication Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.3 Pricing Analysis of Topical and Oral Medication
- 4.4 Patient Population Undergoing Acne Treatment
5. Acne Medication Market - Key Market Dynamics
- 5.1 Acne Medication Market - Key Market Dynamics
- 5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
- 5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
- 5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
- 5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
- 5.6 Impact of Drivers and Restraints:
6. Acne Medication Market - Global Market Analysis
7. Acne Medication Market Analysis - by Therapeutic Class
- 7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8. Acne Medication Market Analysis - by Formulation
- 8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9. Acne Medication Market Analysis - by Type
- 9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10. Acne Medication Market Analysis - by Acne Type
- 10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11. Acne Medication Market Analysis - by Distribution Channel
- 11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
12. Acne Medication Market - Geographical Analysis
- 12.1 Overview
- 12.2 North America
- 12.2.1 Overview
- 12.2.2 North America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.2.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.2.2.2 North America: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.2.2.3 North America: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.2.2.4 North America: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.2.2.5 North America: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.2.3 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.2.3.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.2.3.2 US
- 12.2.3.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.3.2 US: Acne Medication Market Breakdown, by Formulation
- 12.2.3.3.3 US: Acne Medication Market Breakdown, by Type
- 12.2.3.3.4 US: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
- 12.2.3.4 Canada
- 12.2.3.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.5.2 Canada: Acne Medication Market Breakdown, by Formulation
- 12.2.3.5.3 Canada: Acne Medication Market Breakdown, by Type
- 12.2.3.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
- 12.2.3.6 Mexico
- 12.2.3.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.2.3.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
- 12.2.3.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
- 12.2.3.7.3 Mexico: Acne Medication Market Breakdown, by Type
- 12.2.3.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
- 12.2.3.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel
- 12.3 Europe
- 12.3.1 Overview
- 12.3.2 Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.2.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.3.2.2 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.3.2.3 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.3.2.4 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.3.2.5 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.3.3 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.3.3.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.3.3.2 Germany
- 12.3.3.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.3.2 Germany: Acne Medication Market Breakdown, by Formulation
- 12.3.3.3.3 Germany: Acne Medication Market Breakdown, by Type
- 12.3.3.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.4 France
- 12.3.3.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.5.2 France: Acne Medication Market Breakdown, by Formulation
- 12.3.3.5.3 France: Acne Medication Market Breakdown, by Type
- 12.3.3.5.4 France: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.6 UK
- 12.3.3.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.7.2 UK: Acne Medication Market Breakdown, by Formulation
- 12.3.3.7.3 UK: Acne Medication Market Breakdown, by Type
- 12.3.3.7.4 UK: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.8 Italy
- 12.3.3.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.9.2 Italy: Acne Medication Market Breakdown, by Formulation
- 12.3.3.9.3 Italy: Acne Medication Market Breakdown, by Type
- 12.3.3.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.10 Spain
- 12.3.3.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.11.2 Spain: Acne Medication Market Breakdown, by Formulation
- 12.3.3.11.3 Spain: Acne Medication Market Breakdown, by Type
- 12.3.3.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
- 12.3.3.12 Rest of Europe
- 12.3.3.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.3.3.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
- 12.3.3.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
- 12.3.3.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
- 12.3.3.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
- 12.3.3.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel
- 12.4 Asia Pacific
- 12.4.1 Asia Pacific Acne Medication Market Overview
- 12.4.2 Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.2.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.4.2.2 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.4.2.3 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.4.2.4 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.4.2.5 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.4.3 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.4.3.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.4.3.2 China
- 12.4.3.3 China: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.3.1 China: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.3.2 China: Acne Medication Market Breakdown, by Formulation
- 12.4.3.3.3 China: Acne Medication Market Breakdown, by Type
- 12.4.3.3.4 China: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.3.5 China: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.4 Japan
- 12.4.3.5 Japan: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.5.1 Japan: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.5.2 Japan: Acne Medication Market Breakdown, by Formulation
- 12.4.3.5.3 Japan: Acne Medication Market Breakdown, by Type
- 12.4.3.5.4 Japan: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.5.5 Japan: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.6 India
- 12.4.3.7 India: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.7.1 India: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.7.2 India: Acne Medication Market Breakdown, by Formulation
- 12.4.3.7.3 India: Acne Medication Market Breakdown, by Type
- 12.4.3.7.4 India: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.7.5 India: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.8 Australia
- 12.4.3.9 Australia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.9.1 Australia: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.9.2 Australia: Acne Medication Market Breakdown, by Formulation
- 12.4.3.9.3 Australia: Acne Medication Market Breakdown, by Type
- 12.4.3.9.4 Australia: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.9.5 Australia: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.10 South Korea
- 12.4.3.11 South Korea: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.11.1 South Korea: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.11.2 South Korea: Acne Medication Market Breakdown, by Formulation
- 12.4.3.11.3 South Korea: Acne Medication Market Breakdown, by Type
- 12.4.3.11.4 South Korea: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.11.5 South Korea: Acne Medication Market Breakdown, by Distribution Channel
- 12.4.3.12 Rest of Asia Pacific
- 12.4.3.13 Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.4.3.13.1 Rest of Asia Pacific: Acne Medication Market Breakdown, by Therapeutic Class
- 12.4.3.13.2 Rest of Asia Pacific: Acne Medication Market Breakdown, by Formulation
- 12.4.3.13.3 Rest of Asia Pacific: Acne Medication Market Breakdown, by Type
- 12.4.3.13.4 Rest of Asia Pacific: Acne Medication Market Breakdown, by Acne Type
- 12.4.3.13.5 Rest of Asia Pacific: Acne Medication Market Breakdown, by Distribution Channel
- 12.5 Middle East and Africa
- 12.5.1 Overview
- 12.5.2 Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030
- 12.5.2.1 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.5.2.2 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.5.2.3 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.5.2.4 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.5.2.5 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.5.3 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.5.3.1 Middle East and Africa: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.5.3.2 Saudi Arabia
- 12.5.3.3 Saudi Arabia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.3.1 Saudi Arabia: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.3.2 Saudi Arabia: Acne Medication Market Breakdown, by Formulation
- 12.5.3.3.3 Saudi Arabia: Acne Medication Market Breakdown, by Type
- 12.5.3.3.4 Saudi Arabia: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.3.5 Saudi Arabia: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.4 South Africa
- 12.5.3.5 South Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.5.1 South Africa: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.5.2 South Africa: Acne Medication Market Breakdown, by Formulation
- 12.5.3.5.3 South Africa: Acne Medication Market Breakdown, by Type
- 12.5.3.5.4 South Africa: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.5.5 South Africa: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.6 UAE
- 12.5.3.7 UAE: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.7.1 UAE: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.7.2 UAE: Acne Medication Market Breakdown, by Formulation
- 12.5.3.7.3 UAE: Acne Medication Market Breakdown, by Type
- 12.5.3.7.4 UAE: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.7.5 UAE: Acne Medication Market Breakdown, by Distribution Channel
- 12.5.3.8 Rest of Middle East and Africa
- 12.5.3.9 Rest of Middle East and Africa: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.5.3.9.1 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Therapeutic Class
- 12.5.3.9.2 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Formulation
- 12.5.3.9.3 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Type
- 12.5.3.9.4 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Acne Type
- 12.5.3.9.5 Rest of Middle East and Africa: Acne Medication Market Breakdown, by Distribution Channel
- 12.6 South and Central America
- 12.6.1 Overview
- 12.6.2 South and Central America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.1 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Therapeutic Class
- 12.6.2.2 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Formulation
- 12.6.2.3 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Type
- 12.6.2.4 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Acne Type
- 12.6.2.5 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.6.2.6 South and Central America: Acne Medication Market - Revenue and Forecast Analysis - by Country
- 12.6.2.7 Brazil
- 12.6.2.8 Brazil: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.8.1 Brazil: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.8.2 Brazil: Acne Medication Market Breakdown, by Formulation
- 12.6.2.8.3 Brazil: Acne Medication Market Breakdown, by Type
- 12.6.2.8.4 Brazil: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.8.5 Brazil: Acne Medication Market Breakdown, by Distribution Channel
- 12.6.2.9 Argentina
- 12.6.2.10 Argentina: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.10.1 Argentina: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.10.2 Argentina: Acne Medication Market Breakdown, by Formulation
- 12.6.2.10.3 Argentina: Acne Medication Market Breakdown, by Type
- 12.6.2.10.4 Argentina: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.10.5 Argentina: Acne Medication Market Breakdown, by Distribution Channel
- 12.6.2.11 Rest of South and Central America
- 12.6.2.12 Rest of South and Central America: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
- 12.6.2.12.1 Rest of South and Central America: Acne Medication Market Breakdown, by Therapeutic Class
- 12.6.2.12.2 Rest of South and Central America: Acne Medication Market Breakdown, by Formulation
- 12.6.2.12.3 Rest of South and Central America: Acne Medication Market Breakdown, by Type
- 12.6.2.12.4 Rest of South and Central America: Acne Medication Market Breakdown, by Acne Type
- 12.6.2.12.5 Rest of South and Central America: Acne Medication Market Breakdown, by Distribution Channel
13. Acne Medication Market- Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in Acne Medication Market
- 13.3 Organic Growth Strategies
- 13.3.1 Overview
- 13.4 Inorganic Growth Strategies
- 13.4.1 Overview
- 13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
- 14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Mayne Pharma Group Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Almirall SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Johnson & Johnson
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Sun Pharmaceutical Industries Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Bausch Health Companies Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Centro Internacional de Cosmiatria SA de CV
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Galderma SA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Pfizer Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 GSK Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
- 14.11 Viatris Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
- 14.12 Somar Sapi De CV
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
- 14.13 Pierre Fabre SA
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
- 14.14 Carnot Technologies
- 14.14.1 Key Facts
- 14.14.2 Business Description
- 14.14.3 Products and Services
- 14.14.4 Financial Overview
- 14.14.5 SWOT Analysis
- 14.14.6 Key Developments
- 14.15 Italmex SA
- 14.15.1 Key Facts
- 14.15.2 Business Description
- 14.15.3 Products and Services
- 14.15.4 Financial Overview
- 14.15.5 SWOT Analysis
- 14.15.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
